Details

Synthetic biology for designing allostery and its potential biomedical applications
ID Plaper, Tjaša (Author), ID Knez Štibler, Urška (Author), ID Jerala, Roman (Author)

.pdfPDF - Presentation file, Download (2,09 MB)
MD5: 34BE198B411E219344E016437653BE9D
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S0022283625002918 This link opens in a new window

Abstract
Allosteric regulation of protein function, where a perturbation at one site induces a conformational shift or alters dynamics at a distal functional site, plays a key role in numerous biological processes. The ability to introduce allostery using synthetic biology principles holds significant potential both for biomedical and biotechnological applications, and for advancing our understanding of natural allostery. By customizing target proteins for sensing specific chemical or physical signals, including ligand binding and environmental cues, we aim to allosterically modulate the function of a target protein depending on the selected triggers. This approach, unlike active-site targeting, offers greater specificity and selectivity and can allosterically couple diverse physiological processes. Synthetic biology strategies have been developed recently for designed allosteric protein regulation, including the design of allosteric modulators such as domain insertion, generation of de novo allosteric protein switches, and application of engineered allosteric mechanisms to control cellular functions. We examine the application of artificial intelligence (AI)-based generative protein design and other important milestones, challenges and opportunities in this field, highlighting how these approaches could be applied for the development of new therapeutic strategies.

Language:English
Keywords:allostery, protein engineering, domain insertion, protein switch, synthetic biology
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:17 str.
Numbering:Vol. 437, iss. 20, art. 169225
PID:20.500.12556/RUL-181981 This link opens in a new window
UDC:577
ISSN on article:1089-8638
DOI:10.1016/j.jmb.2025.169225 This link opens in a new window
COBISS.SI-ID:259537155 This link opens in a new window
Publication date in RUL:21.04.2026
Views:136
Downloads:49
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of molecular biology
Shortened title:J. mol. biol.
Publisher:Elsevier
ISSN:1089-8638
COBISS.SI-ID:18272551 This link opens in a new window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:Slovenian
Keywords:biokemija, beljakovine, proteini, biološki procesi, celične funkcije, umetna inteligenca

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P4-0176
Name:Sintezna biologija in imunologija

Funder:ARRS - Slovenian Research Agency
Project number:J7-4640
Name:Inovativna imunoterapija raka preko CAR T celic (CARRS)

Funder:ARRS - Slovenian Research Agency
Project number:J7-4493
Name:Mikrofluidična mehanoporacija za celično terapijo

Funder:EC - European Commission
Funding programme:HE
Project number:101059842
Name:Centre of Excellence for the Technologies of Gene and Cell Therapy
Acronym:CTGCT

Funder:EC - European Commission
Funding programme:HE
Project number:101141584
Name:Protein function regulation through inserts for response to biological, chemical and physical signals
Acronym:PROFI

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back